medRxiv · 2022 · 32 citations · 15 references
Life SciencesNeurologyNeuroscienceInflammationNeurobiology Of DiseaseNeuroimmunologyNeuroinflammationNeurologic PathophysiologyNeuropathology Of InfectionIn Vivo StudiesInflammatory NeuropathologyLong CovidNeuroinflammatory BiomarkersNeuroinflammatory Disease BiomarkersNeuroinflammatory Markers
Summary A significant number of COVID-19 patients develop ‘long COVID’, a condition defined by long-lasting debilitating, often neurological, symptoms. The pathophysiology of long COVID is unknown. Here we present in-vivo evidence of widespread neuroinflammation in long COVID, using a quantitative assessment, [ 18 F]DPA-714 PET, in two long COVID patients. We reanalyzed historical data from three matched healthy control subjects, for comparison purposes. Both patients with long COVID had widespread increases in [ 18 F]DPA-714 binding throughout the brain. Quantitative measures of binding (BP ND values) were increased on average by 121% and 76%, respectively. This implicates profound neuroinflammation in the pathophysiology of long COVID.
15
Persistent Symptoms in Patients After Acute COVID-19
Angelo Carfì, Roberto Bernabei, Francesco Landi · JAMA · 2020 · 4.8K citations · Full text
Veterinary Medicine, Infectious Diseases, Internal Medicine +9
Valentina O. Püntmann, Maria Ludovica Carerj, Imke Wieters et al. · JAMA Cardiology · 2020 · 2.3K citations · Full text
Veterinary Medicine, Infectious Diseases, Internal Medicine +10
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series
Jakob Matschke, Marc Lütgehetmann, Christian Hagel et al. · The Lancet Neurology · 2020 · 1.4K citations · Full text
The peripheral benzodiazepine binding site in the brain in multiple sclerosis
Richard B. Banati, Jia Newcombe, Roger N. Gunn et al. · Brain · 2000 · 648 citations · Full text